Marrett, Elizabeth
Kwong, Winghan Jacqueline
Xie, Jipan
Manceur, Ameur M.
Sendhil, Selvam R.
Wu, Eric
Ionescu-Ittu, Raluca
Subramanian, Janakiraman
Funding for this research was provided by:
Daiichi-Sankyo
Article History
Accepted: 2 July 2023
First Online: 2 September 2023
Declarations
:
: This study was funded by Daiichi Sankyo, Inc. The study sponsor was involved in all aspects of the research, including the study design, interpretation of data, and manuscript development.
: Elizabeth Marrett and Winghan Jacqueline Kwong are employees of Daiichi Sankyo. Jipan Xie, Ameur M. Manceur, Selvam R. Sendhil, Eric Wu, and Raluca Ionescu-Ittu are employees of Analysis Group Inc., a consulting company that received funding from Daiichi Sankyo, Inc. for the conduct of this study. Janakiraman Subramanian has served in an advisory role and/or speakers bureau for Astra Zeneca, Axcess, BeiGene, Blueprint Medicines, Boehringer Ingelheim, Cardinal Health, Daiichi Sankyo, Eli Lilly, G1 Therapeutics, Janssen Oncology, Jazz Pharmaceuticals, Novartis, OncoCyte, Pfizer, and Takeda, and has received research funding from Canstem, G1 Therapeutics, Genentech, Helsinn Therapeutics, Incyte, Merck, Novartis, Novocure, and Tesaro/GSK.
: This retrospective database analysis used de-identifed claims data, which is compliant with the Health Insurance Portability and Accountability Act to protect patient privacy. No institutional board review was required.
: Not applicable.
: Not applicable.
: The database used to conduct this study is available from IQVIA with a licensing agreement (ExternalRef removed). Sharing of data supporting the results reported in this article may be considered upon request by contacting emarrett@dsi.com.
: Not applicable.
: EM, WJK, JX, AMM, SRS, EW, RII, and JS developed/approved the protocol. AMM, SRS, and RII analyzed the data. All authors contributed to the interpretation of data, revised the manuscript for intellectual content, and read and approved the final version.<b>Previous presentations</b>Portions of these results were presented in a poster format at the National Comprehensive Cancer Network 2021 Virtual Annual Conference held on 18–20 March, 2021 and the Academy of Managed Care Pharmacy 2021 Virtual Meeting held on 12–16 April, 2021.